BioClonal

BioClonal is focused in Antibody Discovery, offering customized solutions tailored to each specifics needs and goals in the therapeutic mAbs area.
Proprietary development: FIC for Alzheimer's Disease
We partner with pharmaceutical and biotechnology companies worldwide, thanks to our innovative in vivo platform, RedMabs.

Based in a win- win philosophy, we propose long-term agreements of co-discovery and co-development.